We are live on
!
Find out more
PA
PharVision Advisers Portfolio holdings
AUM
$9.86M
1-Year Est. Return
9.93%
This Fund
S&P 500
This Quarter
Est. Return
+0.93%
1 Year Est. Return
+9.93%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$198M
AUM Growth
+$19.8M
(+11%)
Cap. Flow
+$23.3M
Cap. Flow
% of AUM
11.78%
Top 10 Holdings %
Top 10 Hldgs %
3.45%
Holding
1,063
New
409
Increased
141
Reduced
117
Closed
396
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Delek US
DK
|
+$871K |
| 2 |
Broadcom
AVGO
|
+$691K |
| 3 |
Agilent Technologies
A
|
+$650K |
| 4 |
Telos
TLS
|
+$640K |
| 5 |
Pagaya Technologies
PGY
|
+$627K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Array Technologies
ARRY
|
+$730K |
| 2 |
Vertiv
VRT
|
+$639K |
| 3 |
Zevra Therapeutics
ZVRA
|
+$635K |
| 4 |
BOW
Bowhead Specialty Holdings
BOW
|
+$608K |
| 5 |
Rigel Pharmaceuticals
RIGL
|
+$581K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.19% |
| 2 | Industrials | 15.13% |
| 3 | Financials | 12.4% |
| 4 | Consumer Discretionary | 11.79% |
| 5 | Healthcare | 11.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
Marcus Corp
MCS
$766M
| $191K | 0.1% |
+12,338
| New | +$183K |
|
577
Valley National Bancorp
VLY
$8.01B
| $191K | 0.1% |
+16,368
| New | +$182K |
|
578
Eve Holding
EVEX
$853M
| $191K | 0.1% |
+47,794
| New | +$210K |
|
579
Patterson-UTI
PTEN
$3.48B
| $191K | 0.1% |
31,193
+367
| +1% | +$2.19K |
|
580
Ranger Energy Services
RNGR
$345M
| $190K | 0.1% |
+13,625
| New | +$185K |
|
|
JAMF
581
DELISTED
Jamf
JAMF
| $190K | 0.1% |
+14,573
| New | +$177K |
|
582
Kelly Services Class A
KELYA
$560M
| $189K | 0.1% |
21,486
+10,739
| +100% | +$109K |
|
583
Palladyne AI
PDYN
$239M
| $188K | 0.1% |
44,149
+26,064
| +144% | +$175K |
|
584
Genie Energy
GNE
$378M
| $188K | 0.1% |
13,628
-380
| -3% | -$5.59K |
|
585
Viavi Solutions
VIAV
$8.66B
| $187K | 0.09% |
+10,510
| New | +$170K |
|
586
Ardagh Metal Packaging
AMBP
$3.11B
| $185K | 0.09% |
45,119
-17,014
| -27% | -$64.5K |
|
587
Cars.com
CARS
$705M
| $183K | 0.09% |
+15,029
| New | +$175K |
|
588
Ondas Inc
ONDS
$4.48B
| $182K | 0.09% |
+18,641
| New | +$150K |
|
589
Neuropace
NPCE
$522M
| $181K | 0.09% |
11,699
-10,757
| -48% | -$144K |
|
590
Evolent Health
EVH
$421M
| $180K | 0.09% |
44,967
+29,330
| +188% | +$163K |
|
591
QuantumScape Corp
QS
$3.18B
| $179K | 0.09% |
+17,152
| New | +$236K |
|
592
NOV
NOV
$7.11B
| $178K | 0.09% |
+11,416
| New | +$169K |
|
593
BTCS Inc
BTCS
$51.8M
| $176K | 0.09% |
+66,722
| New | +$241K |
|
594
Dole
DOLE
$1.35B
| $175K | 0.09% |
+11,683
| New | +$163K |
|
595
LG Display
LPL
$2.93B
| $171K | 0.09% |
+40,512
| New | +$189K |
|
596
Backblaze
BLZE
$724M
| $170K | 0.09% |
+36,502
| New | +$250K |
|
|
NFBK
597
DELISTED
Northfield Bancorp
NFBK
| $170K | 0.09% |
+14,872
| New | +$165K |
|
|
WSR
598
DELISTED
Whitestone REIT
WSR
| $170K | 0.09% |
12,229
-15,259
| -56% | -$197K |
|
599
CION Investment
CION
$306M
| $169K | 0.09% |
+17,485
| New | +$169K |
|
600
Itaú Unibanco
ITUB
$91.6B
| $167K | 0.08% |
23,256
+7,355
| +46% | +$52.3K |
|
Similar funds
BS
RG
MP
CCM
DFA
CCP
FRT
VH
PharVision Advisers's Q4 2025 Portfolio in Review
As of Q4 2025, PharVision Advisers held 1,063 positions worth $198M, up 11% from $178M the previous quarter. Its ten largest holdings account for 3.5% of the portfolio.
PharVision Advisers deployed $23.3M of net new capital in Q4 2025, opening 409 new positions and adding to 141 existing holdings. Its largest new stake was Delek US: 24,407 shares worth $724K.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Wayfair, an estimated $510K trimmed.
- PharVision Advisers's largest Q4 2025 buy was Delek US: 24,407 shares worth $724K.
- PharVision Advisers added most to NIO in Q4 2025, an estimated $557K increase.
- PharVision Advisers's biggest Q4 2025 reduction was Wayfair, cutting an estimated $510K.
- PharVision Advisers fully exited Array Technologies in Q4 2025, selling an estimated $730K.
- PharVision Advisers's ten largest holdings make up 3.5% of its $198M portfolio in Q4 2025.
- PharVision Advisers opened 409 new positions and closed 396 in Q4 2025.
- PharVision Advisers's portfolio value rose 11% quarter-over-quarter to $198M.
Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.